Vimarsana
Biggest News Aggregation in the World

Exodx Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exodx Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exodx Prostate Today - Breaking & Trending Today

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript - Vimarsana News

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS - Vimarsana News

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS

MINNEAPOLIS, Oct. 31, 2023 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the first quarter ended September 30, 2023. First Quarter FY2024 Highlights First quarter...

Exosome Diagnostics and Therapeutics Market size to grow by USD 483.18 million from 2022 to 2027|Increasing research on exosomes for new therapeutics driving the market - Vimarsana News

Exosome Diagnostics and Therapeutics Market size to grow by USD 483.18 million from 2022 to 2027|Increasing research on exosomes for new therapeutics driving the market

/PRNewswire/ -- The exosome diagnostics and therapeutics market size is set to grow by USD 483.18 million from 2022 to 2027 and register an accelerating CAGR...

Head-To-Head Analysis: Ocugen (NASDAQ:OCGN) and Bio-Techne (NASDAQ:TECH) - Vimarsana News

Head-To-Head Analysis: Ocugen (NASDAQ:OCGN) and Bio-Techne (NASDAQ:TECH)

Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation. Risk & Volatility Bio-Techne has a beta of 1.26, meaning that its […]

Head to Head Survey: Bio-Techne (NASDAQ:TECH) versus Ocugen (NASDAQ:OCGN) - Vimarsana News

Head to Head Survey: Bio-Techne (NASDAQ:TECH) versus Ocugen (NASDAQ:OCGN)

Bio-Techne (NASDAQ:TECH – Get Rating) and Ocugen (NASDAQ:OCGN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility Bio-Techne has a beta of 1.25, suggesting that its […]

Source: wkrb13.com